| |
|
|
|
 |
|
Retrospective Study
Idiosyncratic Liver Injury Associated with Drugs
Purpose | Liver Injury | Participate | Privacy | Requirements | Benefits | Procedures | Download Brochure PDF
Purpose
The purpose of this study is to establish a nationwide registry of people who have experienced idiosyncratic (unusual) liver injury due to taking certain prescribed medications. The four medications are isoniazid (INH), phenytoin (Dilantin), combination clavulanic acid/amoxicillin (Augmentin), or valproic acid (Depakote). It is a nonprofit study sponsored
by the National Institute of Diabetes &
Digestive & Kidney Diseases, U.S. National Institutes
of Health (NIH).
To Top
Liver Injury due to Drugs—A Serious Concern
Liver injury due to drugs is the main reason drugs do
not get approved by the U.S. Food and Drug
Administration or get removed from the market after
initial approval. Through the participation of you
and others like you, we hope to be able to discover
why people have unwanted liver reactions to certain
drugs. Being able to study people who have had such
reactions is the only way we are able to identify the
reasons for these reactions.
To Top
Voluntary Participation
Your participation is entirely voluntary and will not
cost you anything. You will receive a nominal fee to
cover any expenses associated with the study and to
compensate you for your effort.
To Top
Privacy Protection
Your identity will be kept confidential; your name
will not be on the blood sample you give, and any
results of the blood sample will not go into your
medical records. Your records will be kept confidential;
the only people who may review them are representatives
of the NIH, the institutional review board,
and the data coordinating center at the Duke
Clinical Research Institute.
To Top
What will be Required of You
If you decide to take part in this study, you will be
asked to give us permission to look at your medical
records and take a small sample of blood. You will
also be given the option to be followed up, by someone
on the study team contacting you (usually by
phone) once a year, for up to 20 years. You may drop
out of the study at any time. You might also be
offered opportunities to take part in other studies,
but this would be completely up to you.
To Top
Benefits to You and Others
You may receive no direct benefit from this study,
except for the satisfaction of knowing that you have
contributed in an important way to medical research
that may benefit others in the future. If we are able
to discover why people have unwanted reactions to
drugs, we may be able to test people before giving
them medications and prevent these reactions. It
may also make it possible to design safer drugs in the
future, which would benefit everyone.
To Top
The Study Will Proceed as Follows:
- Please review the enclosed consent forms and
the release-of-medical-information form.
Someone connected with the study will call to
go over the documents with you and answer
any questions you may have.
- The study contact person will also schedule a
time(s) to complete a questionnaire (which
can be done over the telephone) and to collect
a blood sample. Both may be able to be
completed at the same visit. For the questionnaire,
you will need the following information:
- Month and year when you started taking
the medication, and month and
year when you started having the liver
problems
- Other drugs and herbal preparations
you were taking around this time
- Names of all the doctors who were
helping you during this time
- Any related information about the
members of your family
- Then you will be asked to sign the consent and
release-of-medical-information forms and provide
them to the DILIN study team.
- Once you have given the blood sample, your
participation has ended for the first year.
Thereafter, someone from the study team will
try to get in touch with you annually just to
keep your contact information up to date.
Remember that you may withdraw from the
study at any time and request that your
blood sample be destroyed.
To Top
|
|
|
|